No standarisation or harmonisation in anti-doping testing frequency

Area of Science:

• Sports Science
• Anti-Doping Research
• Athletics Administration

Background:

• Performance-enhancing drugs (PEDs) have long challenged the integrity of sports, particularly cycling and athletics.
• The World Anti-Doping Agency (WADA) has standardized anti-doping rules but not testing frequency.
• Disparities in testing rates exist globally, impacting the credibility of athletic competitions.

Purpose of the Study:

• To analyze the variations in anti-doping testing frequency across different countries in athletics.
• To investigate the relationship between a country's athletic success and its PED testing rates.
• To highlight potential inequities in global anti-doping enforcement within athletics.

Main Methods:

• Data collection on PED testing rates in athletics from various countries.
• Comparative analysis of testing frequency based on national athletic performance metrics.
• Statistical examination of disparities in testing rates globally.

Main Results:

• Significant global differences in athletics testing rates were observed.
• Several leading athletics nations implement substantially lower testing frequencies compared to others.
• The study reveals a lack of harmonized testing protocols worldwide.

Conclusions:

• Current PED testing frequency in athletics is inconsistent globally.
• Disparities in testing may undermine fair competition and the credibility of anti-doping efforts.
• There is a need for WADA to address and standardize testing frequency in athletics.